- Home
- DNTH vs MRTN Comparison
DNTH vs MRTN Comparison
Compare DNTH & MRTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNTH
- MRTN
- Stock Information
- Founded
- DNTH 2015
- MRTN 1946
- Country
- DNTH United States
- MRTN United States
- Employees
- DNTH N/A
- MRTN N/A
- Industry
- DNTH Biotechnology: Pharmaceutical Preparations
- MRTN Trucking Freight/Courier Services
- Sector
- DNTH Health Care
- MRTN Industrials
- Exchange
- DNTH Nasdaq
- MRTN Nasdaq
- Market Cap
- DNTH 1.0B
- MRTN 959.5M
- IPO Year
- DNTH N/A
- MRTN 1986
- Fundamental
- Price
- DNTH $37.04
- MRTN $11.64
- Analyst Decision
- DNTH Strong Buy
- MRTN Buy
- Analyst Count
- DNTH 9
- MRTN 2
- Target Price
- DNTH $61.57
- MRTN $19.00
- AVG Volume (30 Days)
- DNTH 969.3K
- MRTN 621.6K
- Earning Date
- DNTH 11-06-2025
- MRTN 10-16-2025
- Dividend Yield
- DNTH N/A
- MRTN 2.06%
- EPS Growth
- DNTH N/A
- MRTN N/A
- EPS
- DNTH N/A
- MRTN 0.25
- Revenue
- DNTH $4,854,000.00
- MRTN $920,872,000.00
- Revenue This Year
- DNTH N/A
- MRTN N/A
- Revenue Next Year
- DNTH N/A
- MRTN $4.04
- P/E Ratio
- DNTH N/A
- MRTN $46.59
- Revenue Growth
- DNTH 17.87
- MRTN N/A
- 52 Week Low
- DNTH $13.37
- MRTN $11.43
- 52 Week High
- DNTH $38.59
- MRTN $18.63
- Technical
- Relative Strength Index (RSI)
- DNTH 82.86
- MRTN 43.05
- Support Level
- DNTH $36.00
- MRTN $11.44
- Resistance Level
- DNTH $24.81
- MRTN $11.98
- Average True Range (ATR)
- DNTH 2.70
- MRTN 0.26
- MACD
- DNTH 1.31
- MRTN 0.02
- Stochastic Oscillator
- DNTH 90.18
- MRTN 28.38
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.
About MRTN Marten Transport Ltd.
Marten Transport Ltd is a temperature-sensitive truckload carrier in the United States. The company specializes in transporting and distributing food and other consumer packaged goods that require a temperature-controlled or insulated environment. It operates through four segments: Truckload, Dedicated, Intermodal, and Brokerage, generating the majority of its revenue from the Truckload segment. The Truckload segment offers a mix of regional short-haul and medium- to long-haul full-load transportation services.